Becton Dickinson Net Worth (Updated 2025).

Becton Dickinson, a renowned name in the healthcare industry, was founded in 1897 by Maxwell Becton and Fairleigh Dickinson. The company’s journey began in a small workshop in New Jersey, where they started manufacturing and selling syringes, a novel product at the time. Their first big break came when they secured a contract to supply syringes to the U.S. Army during the Spanish-American War, catapulting their business into the limelight.

As the company grew, so did its product range. Becton Dickinson expanded into the manufacturing of medical needles, intravenous (IV) systems, and other medical devices. Their commitment to quality and innovation earned them a reputation as a trusted supplier to hospitals and healthcare providers worldwide. A significant milestone was reached in 1956 when the company introduced the first disposable syringe, revolutionizing the healthcare industry and further cementing their fame.

**Becton Dickinson’s Current Net Worth (as of 2025):**

As of 2025, Becton, Dickinson and Company (BD) has an estimated net worth of around $65 billion, according to the latest available information. This significant figure is a testament to the company’s robust financial health and success in the global medical technology industry.

**Career:**

BD, founded in 1897, has a rich history spanning over a century. It started as a medical equipment supplier and has since grown into a global medical technology company. Today, BD employs over 70,000 people worldwide, offering a wide range of career opportunities in various fields such as research and development, manufacturing, sales, and more. The company’s commitment to innovation and improving healthcare has made it a sought-after employer in the industry.

**Other Ventures:**

Beyond its core medical technology business, BD has ventured into other areas to diversify its offerings and expand its reach. For instance, BD has a significant presence in the pharmaceutical sector, with its BD UltraSafe™ Passive Drug Transfer System being a notable product. Additionally, the company has invested in digital health technologies, aiming to leverage data and analytics to enhance patient care and clinical workflows.

**Assets:**

BD’s extensive portfolio of assets includes a broad range of medical devices, pharmaceutical systems, and diagnostic products. Some of its leading brands include BD Biosciences, BD Diagnostics, BD Medical, and BD Pharmingen. The company’s global footprint spans over 50 countries, with manufacturing facilities and research centers located across North America, Europe, Asia, and the Middle East. These assets enable BD to serve a wide range of customers, from healthcare institutions to pharmaceutical companies.

**Annual Income:**

In the fiscal year 2021, BD reported a total revenue of $17.1 billion, reflecting a steady growth trajectory. The company’s diverse product portfolio and global presence have contributed to this robust annual income. BD’s consistent financial performance over the years is a testament to its strong business model and commitment to innovation.

Frequently Asked Questions about  Becton Dickinson

Frequently Asked Questions about Becton Dickinson

1. What is Becton Dickinson’s net worth?

Becton Dickinson’s net worth is estimated to be around $65 billion.

2. When was Becton Dickinson founded?

Becton Dickinson was founded in 1897.

3. Where is Becton Dickinson’s headquarters located?

Becton Dickinson’s headquarters is located in Franklin Lakes, New Jersey, United States.

4. What does Becton Dickinson do?

Becton Dickinson is a global medical technology company that manufactures and sells a broad range of medical devices, instrument systems, and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.

5. How many employees does Becton Dickinson have?

As of 2021, Becton Dickinson has approximately 45,000 employees worldwide.

6. What are some of Becton Dickinson’s products?

Some of Becton Dickinson’s products include syringes, needles, intravenous (IV) systems, diagnostic instruments, and safety-engineered devices designed to help prevent the spread of infections.

7. Who is the CEO of Becton Dickinson?

The current CEO of Becton Dickinson is Tom Polen.

8. What is Becton Dickinson’s stock symbol?

Becton Dickinson’s stock symbol is BDX and it is listed on the New York Stock Exchange (NYSE).

9. What is Becton Dickinson’s revenue?

Becton Dickinson’s annual revenue is approximately $16 billion.

10. How many countries does Becton Dickinson operate in?

Becton Dickinson operates in approximately 190 countries worldwide.